USFDA5 Dec 2025, 01:35 pm
Godavari Biorefineries Granted US Patent for Anti-Cancer Compounds
AI Summary
Godavari Biorefineries Ltd has been granted a US patent for 'COMPOUNDS FOR THE INHIBITION OF UNREGULATED CELL GROWTH' from the Anti-Cancer Research Segment. The patent discloses novel chemical compounds, their synthesis process and biological activity, which inhibit unregulated cell growth by primarily targeting cancer stem cells. These compounds have demonstrated strong potential for treating various cancers, including breast and prostate cancer.
Key Highlights
- Godavari Biorefineries Ltd has been granted a US patent for 'COMPOUNDS FOR THE INHIBITION OF UNREGULATED CELL GROWTH'
- The patent is from the Anti-Cancer Research Segment
- The compounds inhibit unregulated cell growth, primarily targeting cancer stem cells
- The compounds have demonstrated strong potential for treating various cancers, including breast and prostate cancer